|
|||||
|
|
68Ga-PSMA-11 PET-CT study in prostate cancer patients with biochemical recurrence and non-contributive 18F-Choline PET-CT: Impact on therapeutic decision-making and biomarker changes |
|
| Authors: | Matthieu Barbaud MD Mathieu Frindel PD PhD Ludovic Ferrer PhD Maelle Le Thiec MD Daniela Rusu MD Aurore Rauscher PD PhD Bruno Maucherat MD Pierre Baumgartner PD Vincent Fleury MD Mathilde Colombié MD Agnes Thierry-Morel MD Françoise Kraeber-Bodéré MD PhD Loïc Campion MD Caroline Rousseau MD PhD |
| Affiliation: | 1. Nuclear Medicine Unit, ICO Cancer Center, Saint Herblain, Pays de la Loire, France;2. Pharmacy Unit, ICO Cancer Center, Saint Herblain, Pays de la Loire, France;3. Physics Unit, ICO Cancer Center, Saint Herblain, Pays de la Loire, France CRCINA, University of Nantes, INSERM UMR1232, CNRS-ERL6001, Nantes, Pays de la Loire, France;4. Nuclear Medicine Unit, ICO Cancer Center, Saint Herblain, Pays de la Loire, France CRCINA, University of Nantes, INSERM UMR1232, CNRS-ERL6001, Nantes, Pays de la Loire, France;5. CRCINA, University of Nantes, INSERM UMR1232, CNRS-ERL6001, Nantes, Pays de la Loire, France Biometrics Unit, ICO Cancer Center, Nantes, France |
| Abstract: | |
| Keywords: | choline PET-CT prostate cancer PSMA PET-CT recurrence restaging |